Back
Delcath Systems 10K Form
Buy
60
DCTH
Delcath Systems
Last Price:
5.29
Seasonality Move:
-7.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-13 | 10Q | DCTH/Delcath Systems Quarterly |
2023-08-09 | 10Q | DCTH/Delcath Systems Quarterly |
2023-05-22 | 10Q | DCTH/Delcath Systems Quarterly |
2022-11-08 | 10Q | DCTH/Delcath Systems Quarterly |
2022-08-08 | 10Q | DCTH/Delcath Systems Quarterly |
2022-05-11 | 10Q | DCTH/Delcath Systems Quarterly |
Receive DCTH News And Ratings
See the #1 stock for the next 7 days that we like better than DCTH
DCTH Financial Statistics
Sales & Book Value
Annual Sales: | $2.07M |
---|---|
Cash Flow: | $-8.2M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.69 |
Price / Book: | 8.55 |
Profitability
EPS (TTM): | -2.82000 |
---|---|
Net Income (TTM): | $-47.68M |
Gross Margin: | $1.43M |
Return on Equity: | -1118.2% |
Return on Assets: | -153.11% |
Delcath Systems Earnings Forecast
Key Delcath Systems Financial Ratios
- The Gross Profit Margin over the past 19 years for DCTH is 69.25%.
- The Selling, General & Administrative Expenses for DCTH have been equal to 1,070.70% of Gross Profit Margin.
- The Research & Development expenses have been 847.55% of Revenue.
- The Interest Expense is -3.02% of Operating Income.
- The Net Earning history of DCTH is -2,308.86% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 10 years.
Delcath Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | DCTH |
CUSIP: | 24661P |
Website: | delcath.com |
Debt
Debt-to-Equity Ratio: | 0.64 |
---|---|
Current Ratio: | 2.26 |
Quick Ratio: | 2 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
DCTH Technical Analysis vs Fundamental Analysis
Buy
60
Delcath Systems (DCTH)
is a Buy
Is Delcath Systems a Buy or a Sell?
-
Delcath Systems stock is rated a Buy
The current Delcath Systems [DCTH] share price is $5.30. The Score for DCTH is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.